Al's Comment:

 This article reports on very impressive results for an experimental vaccine therapy for high grade gliomas with the IDH1 mutation.  It is a small phase 1 trial (and we have seen great results in small phase 1 trials not pan out in larger phase 3 trials) but I am optimistic on this one. 

Posted on: 03/25/2021

A vaccine targeting mutant IDH1 in newly diagnosed glioma


Click HERE to return to brain tumor news headlines.